• SENSEX 81,425.15
    323.83 (+0.40%)
  • BANKNIFTY 54,536.00
    319.90 (+0.59%)
  • N S D L
    1,301.00 880.00(%)
  • Vikram Solar
    407.85 407.85(%)
  • Kotak Mah. Bank
    1,990.00 2,301.55(%)
  • Avanti Feeds
    767.45 965.00(%)
  • Waaree Energies
    3,501.00 3,740.75(%)
  • MIC Electronics
    78.02 114.74(%)
  • Netweb Technol.
    3,217.95 3,312.00(%)
  • Bharat Electron
    389.00 435.95(%)
  • ICICI Bank
    1,416.35 1,494.10(%)
  • Timken India
    3,030.00 3,955.10(%)
  • TCS
    3,122.00 4,548.00(%)
  • Maruti Suzuki
    15,077.60 10,725.00(%)
  • Oracle Fin.Serv.
    9,299.00 13,203.60(%)
  • One Mobikwik
    299.35 218.85(%)
  • Infosys
    1,534.50 2,006.80(%)
  • Mamata Machinery
    492.00 649.00(%)
  • Vodafone Idea
    7.50 13.75(%)
  • M & M
    3,592.15 2,360.45(%)
  • Reliance Industr
    1,388.65 1,551.00(%)
  • Welspun Living
    128.25 188.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7690.0
  • ISIN : INE858L01010
68.66 1 (1.99%)
  • As on 10 Sep 2025 (EOD)

  • Today’s Low

    68.66

  • Today’s High

    68.66

  • Open

    68.66

  • Perv Close

    67.32

  • 52W Low

    26.10

  • 52W High

    68.66

Key Indicators

  • P/E(TTM)

    171.65

  • Mar.Cap (₹Cr.)

    68.66

  • Div & Yield %

    0.00

  • Book Value(₹)

    34.11

  • Debt-Equity Ratio

    1.99

  • AGM Date

    10-Sep-2025

  • EPS

    0.40

  • P/E Ratio

    171.65

Financials Ratios

  • Debt-Equity Ratio

    0.53

  • Mar.Cap (₹Cr.)

    68.66

  • RONW (%)

    1.43

  • ROCE (%)

    4.76

Score Board

  • Equity (₹ in Cr.)

    10.00

  • BV (₹)

    34.10

  • Sales( ₹ in Cr.)

    36.93

  • NP (in Cr.)

    0.30

  • NP Var(%)

    -29.0

  • Div%

    0.0

  • CPS (₹)

    1.70

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    67.32

  • 52 Week High

    68.66

  • 52 Week Low

    26.10

  • Price BSE

    67.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    67.32

  • P/C Ratio

    39.10

  • P/E Ratio

    226.60

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 43.26 51.31 58.96 51.36 51.34 48.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 43.26 51.31 58.96 51.36 51.34 48.08
Other Income 0.01 0.01 0.10 3.86 0.12 0.09
Stock Adjustments 0.40 -0.52 2.31 -1.69 -0.52 -0.46
Total Income 43.67 50.80 61.37 53.53 50.94 47.71
EXPENDITURE :            
Raw Materials 33.71 40.36 44.41 41.28 42.06 39.14
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.77 0.78
Employee Cost 3.87 3.55 4.14 3.47 3.27 2.29
Other Manufacturing Expenses 0.39 0.44 0.43 0.60 0.40 0.41
Selling and Administration Expenses 1.81 2.05 1.52 1.03 0.95 0.77
Miscellaneous Expenses 0.21 0.06 5.19 0.07 0.04 0.58
Employee Benefit Expenses 3.87 3.55 4.14 3.47 3.27 2.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 39.99 46.46 55.67 46.45 47.48 43.96
Operating Profit 3.69 4.35 5.69 7.08 3.46 3.74
Interest 1.59 1.62 1.68 1.42 1.54 1.59
Gross Profit 2.10 2.73 4.01 5.66 1.92 2.15
Depreciation 1.54 1.60 1.76 1.37 1.46 1.71
Profit Before Tax 0.56 1.13 2.25 4.29 0.46 0.44
Current Tax 0.20 0.35 0.67 0.47 0.12 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.06 -0.11 -0.02 0.54 0.01 -0.08
Reported Net Profit 0.42 0.89 1.59 3.28 0.33 0.41
Extraordinary Items 0.00 0.00 0.00 2.88 0.00 0.00
Adjusted Net Profit 0.42 0.89 1.59 0.40 0.33 0.41
Adjustment below Net Profit 0.00 0.00 0.01 0.00 0.00 0.00
P & L Balance brought forward 14.40 13.51 11.91 8.63 8.30 7.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.82 14.40 13.51 11.91 8.63 8.30
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.42 0.96 1.82 3.75 0.38 0.52
Earnings Per Share(Adj)-Unit Curr 0.42 0.96 1.82 3.75 0.38 0.52
Book Value 33.82 33.43 32.44 30.61 26.86 29.45
Book Value(Adj)-Unit Curr 33.82 33.43 32.44 30.61 26.86 29.45

Shareholding Pattern

  • Promoter Group

    54.39%

  • Public Share Holding

    45.61%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,439,204 54.39 5,439,204 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,439,204 54.39 5,439,204 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 2,086 0.02 2,086 7
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 301,573 3.02 301,573 35
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,576,998 15.77 1,576,998 22
Individuals holding nominal share capital up to Rs. 1 lakh 2,680,139 26.80 2,088,739 5,122
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,560,796 45.61 3,969,396 5,186
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,000,000 100.00 9,408,600 5,189

Company Background

Concord Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Drugs Ltd
  • BSE Code : 7690.0
  • ISIN : INE858L01010

  • Incorporation Year

    1995

  • Registered Office

    Survey No 249 Brahmanapally V
    Hayathnagar M, Ranga Reddy,
    Telangana-501511

  • Telephone

    91-40-24036379

  • FAX

  • Chairman

    S Nagi Reddy

  • Managing Director

    S Nagi Reddy

  • Company Secretary

    Namratha Nagla

  • Auditor

    Pundarikashyam and Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Concord Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Drugs 68.66 43.27 43.26 171.65 4.25
Abbott India 31,295.70 6,684.73 6,409.15 45.79 44.95
Astrazeneca Phar 8,984.60 1,756.92 1,716.29 122.51 32.94
P & G Health Ltd 6,331.90 944.52 934.17 34.97 40.23
Glaxosmi. Pharma 2,833.60 3,866.05 3,723.49 50.95 58.72
Cipla 1,563.70 20,029.57 19,044.85 23.37 21.40
Amrutanjan Healt 754.60 469.50 451.82 40.01 21.89
Guj. Themis Bio. 378.20 152.47 150.80 92.47 27.21
Fermenta Biotec. 351.85 442.21 430.53 11.67 17.61
Bliss GVS Pharma 152.65 703.42 667.20 22.82 9.16
Ambalal Sarabhai 31.89 19.33 4.04 16.70 2.10